Abstract
Transplanted myeloproliferative disease developed in mice against the background of repeated injections of granulocytic CSF was characterized using morphological and molecular biological methods. It was demonstrated that transplanted myeloproliferative disease had a non-viral nature and is probably induced by repeated injections of granulocytic CSF. Tumor cells actively populate the liver of sick animals, which leads to their rapid death. Expression of Myc, Abl, G-CSF, and MPO genes is enhanced, which is typical of myeloid neoplastic transformation.
Similar content being viewed by others
References
L. Brown, S. Boswell, L. Raj, and S. W. Lee, Crit Rev. Eukaryot. Gene Expr., 17, 73–85 (2007).
C. Kaplinsky, L. Trakhtenbrot, I. Hardan, et al., Bone Marrow Transplant., 32, 31–34 (2003).
G. Carlsson, A. A. Aprikyan, R. Tehranchi, et al., Blood, 103, 3355–3361 (2004).
T. Hasegawa, K. Suzuki, C. Sakamoto, et al., Blood, 101, 1164–1171 (2003).
J. M. Hernandez, C. Castilla, N. C. Gutierrez, et al., Leukemia, 19, 1088–1091 (2005).
S. C. Kogan, J. M. Ward, M. R. Anver, J. J. Berman, et al., Blood, 100, 238–245 (2002).
J. C. Kovacic, P. Macdonald, J. Freund, et al., Am. J. Hematol., 82, 229–230 (2007).
Y. Li, J. Lu, and E. V. Prochownik, Proc. Natl. Acad. Sci. USA., 104, 3490–3495 (2007).
K. Makita, K. Ohta, A. Mugitani, et al., Bone Marrow Transplant., 33, 661–665 (2004).
E. Passegue, E. F. Wagner, and I. L. Weissman, Cell, 119, 431–443 (2004).
G. C. Prendergast, Oncogene, 18, 2967–2987 (1999).
R. Ren, Nat. Rev. Cancer. 5, 172–183 (2005).
A. W. Roberts, Growth Factors. 23, 33–41 (2005).
P. Szumilas, K. Barcew, M. Baskiewicz-Masiuk, et al. Cell Prolif., 38, 47–61 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 145, No. 2, pp. 234–240, February, 2008
Rights and permissions
About this article
Cite this article
Bigildeev, A.E., Sats, N.V., Grishchuk, A.L. et al. Characteristics of transplanted mouse myeloproliferative disease developed after repeated injections of granulocytic colony-stimulating factor. Bull Exp Biol Med 145, 270–275 (2008). https://doi.org/10.1007/s10517-008-0068-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-008-0068-8